Literature DB >> 1351369

Thrombospondin and other possible related matrix proteins in malignant and benign breast disease. An immunohistochemical study.

S Y Wong1, A T Purdie, P Han.   

Abstract

Thrombospondin (TSP), which plays an important hemostatic role, is a 450-kd cytoadhesive protein present in the alpha granules of platelets. In vitro experiments using cultured malignant cells suggest that it may help to mediate malignant cell attachment to extracellular matrix and may be important in cancer invasiveness. The authors studied a group of malignant and benign breast tissues for the expression of TSP and provide evidence that TSP may have a role in tumor invasiveness. Using immunohistochemical techniques, the authors found in 48 fresh specimens of breast carcinoma that TSP stained strongly in the desmoplastic stroma or at the basement membrane associated with the malignant ductal epithelium. Tumor cells abutting these tissues revealed cytoplasmic staining for TSP. Stronger TSP staining was seen in the poorly differentiated tumors. These findings were compared with those of normal and benign breast tissue, which showed no TSP staining apart from reactivity in the large distended cysts of fibrocystic disease and faint staining in the stroma of fibroadenomas. Staining for integrin was positive in lymphocytes of both malignant and benign breast disease and equivocally also in the stromal cells of the breast cancer tissue. Immunoreactivity to TSP in tissues was also compared with that of fibronectin, laminin, and collagen type I, III, and IV. The overall findings suggest that thrombospondin may have a role in the tumor biology of invasiveness.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1351369      PMCID: PMC1886533     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  31 in total

1.  Isolation and characterization of a high molecular weight glycoprotein from human blood platelets.

Authors:  J W Lawler; H S Slayter; J E Coligan
Journal:  J Biol Chem       Date:  1978-12-10       Impact factor: 5.157

Review 2.  Use of basement membrane markers in tumour diagnosis.

Authors:  A J d'Ardenne
Journal:  J Clin Pathol       Date:  1989-05       Impact factor: 3.411

3.  Characterization of two murine monoclonal antibodies (P10, P12) directed against different determinants on human blood platelet thrombospondin.

Authors:  P Clezardin; J L McGregor; M Lyon; K J Clemetson; J Huppert
Journal:  Eur J Biochem       Date:  1986-01-02

Review 4.  Adhesion receptors of the immune system.

Authors:  T A Springer
Journal:  Nature       Date:  1990-08-02       Impact factor: 49.962

Review 5.  Fibronectins.

Authors:  R O Hynes
Journal:  Sci Am       Date:  1986-06       Impact factor: 2.142

Review 6.  Integrins: a family of cell surface receptors.

Authors:  R O Hynes
Journal:  Cell       Date:  1987-02-27       Impact factor: 41.582

7.  Presence of type IV collagen and vitronectin in elastosis.

Authors:  D Verhoeven; N Bourgeois; N Buyssens
Journal:  Am J Clin Pathol       Date:  1989-04       Impact factor: 2.493

8.  Detection of estrogen receptor proteins in breast tumors using an improved APAAP immunohistochemical technique.

Authors:  S Y Wong; E D Carrol; S Y Ah-See; H F Sewell
Journal:  Cancer       Date:  1988-11-15       Impact factor: 6.860

9.  Analysis of platelet adhesion with a radioactive chemical crosslinking reagent: interaction of thrombospondin with fibronectin and collagen.

Authors:  J Lahav; M A Schwartz; R O Hynes
Journal:  Cell       Date:  1982-11       Impact factor: 41.582

10.  Thrombospondin in malignant and non-malignant breast tissue.

Authors:  D A Pratt; W R Miller; J Dawes
Journal:  Eur J Cancer Clin Oncol       Date:  1989-02
View more
  25 in total

1.  Thrombospondin 1 protein expression relates to good prognostic indices in ductal carcinoma in situ of the breast.

Authors:  A J Rice; M A Steward; C M Quinn
Journal:  J Clin Pathol       Date:  2002-12       Impact factor: 3.411

Review 2.  Angiogenesis, thrombospondin, and ductal carcinoma in situ of the breast.

Authors:  A Rice; C M Quinn
Journal:  J Clin Pathol       Date:  2002-08       Impact factor: 3.411

3.  Expresson of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas.

Authors:  O Straume; L A Akslen
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

Review 4.  Markers of tumor angiogenesis: clinical applications in prognosis and anti-angiogenic therapy.

Authors:  S B Fox; A L Harris
Journal:  Invest New Drugs       Date:  1997       Impact factor: 3.850

5.  Platelet factors induce chemotactic migration of murine mammary adenocarcinoma cells with different metastatic capabilities.

Authors:  M A Sarach; R A Rovasio; A R Eynard
Journal:  Int J Exp Pathol       Date:  1993-10       Impact factor: 1.925

Review 6.  Role of thrombospondin 1 in liver diseases.

Authors:  Yanzhang Li; Courtney P Turpin; Shuxia Wang
Journal:  Hepatol Res       Date:  2016-08-30       Impact factor: 4.288

7.  The role of the tumor microenvironment in regulating angiogenesis.

Authors:  Randolph S Watnick
Journal:  Cold Spring Harb Perspect Med       Date:  2012-12-01       Impact factor: 6.915

8.  Estrogen regulation of thrombospondin-1 in human breast cancer cells.

Authors:  Salman M Hyder; Yayun Liang; Jianbo Wu
Journal:  Int J Cancer       Date:  2009-09-01       Impact factor: 7.396

9.  Scatter factor binds to thrombospondin and other extracellular matrix components.

Authors:  K Lamszus; A Joseph; L Jin; Y Yao; S Chowdhury; A Fuchs; P J Polverini; I D Goldberg; E M Rosen
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

10.  Thrombospondin 1 expression and angiogenesis in breast carcinoma and their relation with platelet activity.

Authors:  Cigdem Tokyol; Gulriz Ersoz; Fatma Husniye Dilek; Ercan Gencer; Mehmet Nuri Kosar; Osman Nuri Dilek
Journal:  Ups J Med Sci       Date:  2009       Impact factor: 2.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.